Future Medicines: A CPI and University of Strathclyde Partnership Insight Session
The pharmaceutical industry is constantly evolving and there is an increased demand for lower cost drugs, rapid manufacturing and a more patient-centric approach. How new medicines are designed and created is changing, and collaboration between universities and Catapults is crucial in helping to successfully scale and commercialise innovative new solutions in this space.
This webinar is intended to be the first in a series of partnership insight sessions between CPI and the University of Strathclyde. Representatives from both organisations will showcase capabilities and discuss project ideation, with a particular focus on the Medicines Manufacturing Innovation Centre’s future Grand Challenges.
In this webinar, we’ll talk about:
- Intro to CPI/University of Strathclyde strategic partnership
- The Medicines Manufacturing Innovation Centre
- The University of Strathclyde’s work in Future Medicine
This webinar is for staff from CPI and the University of Strathclyde only.
Professor Nick Tomkinson — Professor of Pure and Applied Chemistry at the University of Strathclyde
Nick Tomkinson studied Chemistry at The University of Sheffield and received his BSc in 1992 and his Ph.D. in 1995 under the supervision of Dr. D. Neville Jones and Professor Jim Anderson. Postdoctoral studies with Dr. Tim Willson at GlaxoSmithKline, Research Triangle Park, North Carolina (1996 – 1998) followed.
Nick was appointed to the staff at Cardiff University in 1999 and was an EPSRC Advanced Research Fellowship (2004 – 2009). He moved to his current position at the University of Strathclyde in June 2011.
Professor Glenn Burley — Professor of Chemical Biology at the University of Strathclyde
Glenn A. Burley (GAB) is Professor of Chemical Biology at the University of Strathclyde. The main focus of GAB’s research programme is the development of molecular probes to further our understanding of processes involved in gene expression. GAB was awarded a Bachelor of Medicinal Chemistry (Hon. I) and a PhD in Organic Chemistry from the University of Wollongong, Australia.
GAB was a post-doctoral fellow in the Fullerene Science Centre at the University of Sussex (2001 – 2003) and an Alexander von Humboldt Fellow at the University of Munich (2004 – 2006). GAB began his independent career as an EPSRC Advanced Fellow in 2007 at the University of Leicester, before moving to Strathclyde in 2011.
Dr Craig Jamieson — Reader within the Department of Pure and Applied Chemistry at the University of Strathclyde
Craig Jamieson earned his BSc (Hons) in Chemistry at the University of Glasgow in 1996. His PhD studies were carried out under the direction of Professor R Ramage at the University of Edinburgh (1999). Following postdoctoral research under the supervision of Professor S V Ley at the University of Cambridge, in 2001 he was appointed as a Principal Scientist in GlaxoSmithKline’s Discovery Medicinal Chemistry group working on a range of exploratory medicinal chemistry programmes.
In 2004, Dr Jamieson joined Organon Laboratories (later Merck Research Labs) as a Group Leader in the Medicinal Chemistry Department, with responsibility for hit to clincal candidate optimisation. In August 2010 he was appointed as a John Anderson Research Lecturer in Chemical Biology, based in the Department of Pure and Applied Chemistry at the University of Strathclyde.
Arun Harish — Director of Strategy at CPI
Arun leads strategies for CPI’s sustainable growth and impact generation.
Since joining CPI in 2008, Arun has held diverse roles spanning technology commercialisation, innovation consulting, fund-raising from private and public sources and business development. He has also shaped the development of CPI’s National Healthcare Photonics Centre and the Medicines Manufacturing Innovation Centre.
John Arthur — Director of the Medicines Manufacturing Innovation Centre
John is responsible for delivering the Operational strategy for the Medicines Manufacturing Innovation Centre. Prior to joining CPI, John was a Strategy Director at GSK responsible for the Pharma Supply Chain Strategy, a programme with a goal to increase the productivity of all elements of the manufacturing supply chain. John has over 30 years’ experience at GSK in a range of technical, manufacturing leadership and global programme roles.
John has a BSc in Chemistry from Loughborough University and an MBA from Strathclyde University. He’s a hopeless but enthusiastic golfer, has a double decker bus licence and is a private pilot.